Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
251 Ballardvale St , Wilmington, MA, 01887, US
ATP-bioluminescence and regulatory advancements address unmet manufacturing and testing needs.
Synnott has extensive experience in global CRO operations and management and brings more than 20 years of experience in biomedical research.
By: Charlie Sternberg
Novartis cuts approximately 430 employees from East Hanover HQ, and 34 employees in San Diego.
By: Kristin Brooks
Will conduct an immunohistochemistry study to accelerate HT-KIT.
CGMP cytokines now available for Charles River’s Cell Therapy Flex Platform.
Offers biotechnology developers access to scientific expertise and an ecosystem of discovery, development and manufacturing services.
Alliance aims to advance ADC development and manufacturing services.
Provides early insights into how therapeutics interact with non-human protein targets in vitro.
Charles River will serve as the CDMO to produce the drug products for FibroBiologics’ upcoming clinical trial.
Quotient Sciences' chief executive talks about how the CDMO is positioning itself to stay ahead of the curve.
By: Tim Wright
Exploring how CDMO specialization is addressing scalability and making advanced cell-based therapies possible.
Terumo BCT and Charles River partner on cell therapy innovation.
Charles River will help advance the FRF’s gene therapy through clinical trials.
Will develop the plasmid DNA for AAVantgarde’s Stargardt’s disease program (AAVB-039), using its AAV-intein platform.
The Gates Institute will leverage Charles River’s cell and gene therapy CDMO expertise to develop lentiviral vectors for use in CAR T-cell therapies.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
